IL6 and breast cancer: MDSCs in breast cancer induce IL-6-dependent STAT3 phosphorylation and NOTCH activation via nitric oxide (NO), resulting in prolonged STAT3 activation, which enhances the stem cell-like properties of breast cancer stem cells and inhibits T-cell activation to promote tumor formation [125].